Out-of-pocket health care expenditures, by insurance status, 2007-10.

Out-of-pocket health care spending in the United States totaled $306.2 billion in 2010 and represented 11.8 percent of total national health expenditures, according to the Centers for Medicare and Medicaid Services' National Health Expenditure Accounts.

Reconciling medical expenditure estimates from the MEPS and NHEA, 2007.

Objective: Provide a comparison of health care expenditure estimates for 2007 from the Medical Expenditure Panel Survey (MEPS) and the National Health Expenditure Accounts (NHEA). Reconciling these estimates serves two important purposes. First, it is an important quality assurance exercise for improving and ensuring the integrity of each source's estimates.

Health spending projections through 2017: the baby-boom generation is coming to Medicare.

The outlook for national health spending calls for continued steady growth. Spending growth is projected to be 6.7 percent in 2007, similar to its rate in 2006.

National health spending in 2006: a year of change for prescription drugs.

In 2006, U.S. health care spending increased 6.

Health spending projections through 2016: modest changes obscure part D's impact.

Growth in national health spending is projected to slow slightly from 6.9 percent in 2005 to 6.8 percent in 2006, marking the fourth consecutive year of a slowing trend.

Reconciling medical expenditure estimates from the MEPS and NHEA, 2002.

The Medical Expenditure Panel Survey (MEPS) and National Health Expenditure Accounts (NHEA) are often used for health care policy analysis and simulations because they contain comprehensive estimates of national health care expenditures. The NHEA are primarily based on aggregate provider revenue data, while MEPS is based on person-level data on health care expenditures. This article compares MEPS and NHEA expenditure estimates for 2002 and discusses the differences.

National health spending in 2005: the slowdown continues.

In 2005, U.S. health care spending increased 6.

National health spending in 2004: recent slowdown led by prescription drug spending.

U.S. health care spending rose 7.

Financing Health Care: Businesses, Households, and Governments, 1987-2003.

This article provides estimates of health care expenditures by businesses, households, and governments for 1987-2003. Sponsors that finance public and private health insurance programs and other payers face increasing challenges as health care cost rise. Their capacity to support rising costs was particularly strained during the recent economic recession, with the Federal Government's burden measured against revenue available for this purpose growing faster than for other sponsors.

Health spending growth slows in 2003.

The pace of health spending growth slowed in 2003 for the first time in seven years, driven in part by a slowdown in public spending growth. U.S.

National health expenditures, 2002.

National health expenditures (NHE) were $1.6 trillion in 2002, a 9.3-percent increase from 2001.

Health spending rebound continues in 2002.

U.S. health care spending climbed to dollars 1.

Trends in U.S. health care spending, 2001.

U.S. health care spending grew 8.

Burden of health care costs: businesses, households, and governments, 1987-2000.

In this article, we estimate expenditures by businesses, households, and governments in providing financing for health care for 1987-2000 and track measures of burden that these costs impose. Although burden measures for businesses and the Federal Government have stabilized or improved since 1993, measures of burden for State and local governments are deteriorating slightly--a situation that is likely to worsen in the near future. As health care spending accelerates and an economy wide recession seems imminent, businesses, households, and governments that finance health care will face renewed health cost pressures on their revenue and income.

Health Care Indicators.

THIS REGULAR FEATURE OF THE JOURNAL INCLUDES A DISCUSSION OF EACH OF THE FOLLOWING FOUR TOPICS: community hospital statistics; employment, hours, and earnings in the private health sector; health care prices; and national economic indicators. These statistics are valuable in their own right for understanding the relationship between the health care sector and the overall economy. In addition, they allow us to anticipate the direction and magnitude of health care cost changes prior to the availability of more comprehensive data.

Health Care Indicators.

THIS REGULAR FEATURE OF THE JOURNAL INCLUDES A DISCUSSION OF EACH OF THE FOLLOWING FOUR TOPICS: community hospital statistics; employment, hours, and earnings in the private health sector; health care prices; and national economic indicators. These statistics are valuable in their own right for understanding the relationship between the health care sector and the overall economy. In addition, they allow us to anticipate the direction and magnitude of health care cost changes prior to the availability of more comprehensive data.

Consequences of larval intraspecific competition to stonefly growth and fecundity.

We conducted experiments in replicated circular streams to measure the effect of intraspecific larval density on growth rates, size at emergence, timing of emergence, and fecundity of two species of predatory stoneflies (Megarcys signata and Kogotus modestus, Perlodidae). Early instars of both species showed no significant effect of intraspecific larval density on mean growth rates, despite the observation that in the absence of competitors stoneflies ate on average, significantly more prey (Baetis bicaudatus, Ephemeroptera, Baetidae) than in the presence of competitors. However, larval size of stoneflies held at higher densities (two per chamber) diverged over time, resulting in a greater size variability (coefficient of variation) among Kogotus than in treatments with low densities of stoneflies (one per chamber).